Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: ZYMERON CORPORATION
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2020-08-21 to 2022-08-20
Current total value of award: $300000
Description: EO14042 SBIR PHS 2020-1, TOPIC 084 ENTITLED "ANTIVIRAL DRUGS TO CURE CHRONIC HEPATITIS B VIRUS INFECTION"